The Radiopharmaceuticals in Nuclear Medicine Market is Estimated To Witness High Growth Owing To Increasing Demand for Diagnostic Procedures
The Radiopharmaceuticals in Nuclear Medicine Market is estimated to be valued at US$ 9115.96 Mn in 2023 and is expected to exhibit a CAGR of 8.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. The Radiopharmaceuticals in Nuclear Medicine Market: Radiopharmaceuticals are radioactive pharmaceuticals used in the diagnostic and...
0 Reacties 0 aandelen 1651 Views 0 voorbeeld
Sponsor